Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-01 Tax Withholding |
2025-04-04 5:16 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
5,452 | $8.07 | 226,348 (Direct) |
View |
2025-01-02 Option Award |
2025-01-06 4:59 pm |
N/A 2035-01-02 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
155,068 | $0 | 327,521 (Direct) |
View |
2025-01-02 Tax Withholding |
2025-01-06 4:59 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
12,630 | $7.73 | 327,521 (Direct) |
View |
2024-08-01 Option Award |
2024-08-05 6:38 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
58,867 | $0 | 185,083 (Direct) |
View |
2024-06-28 Option Award |
2024-08-05 6:38 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,363 | $9.945 | 185,083 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 4:22 pm |
N/A 2034-01-02 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
99,512 | $0 | 185,903 (Direct) |
View |
2023-06-30 Option Award |
2024-01-04 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,123 | $16.99 | 185,903 (Direct) |
View |
2022-06-30 Option Award |
2024-01-04 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
728 | $21 | 185,903 (Direct) |
View |
2024-01-02 Tax Withholding |
2024-01-04 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
8,410 | $17.95 | 185,903 (Direct) |
View |
2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-03 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
118,916 | $0 | 145,936 (Direct) |
View |
2023-01-03 Tax Withholding |
2023-01-05 4:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
2,058 | $22.68 | 145,936 (Direct) |
View |
2022-01-03 Option Award |
2022-01-04 9:04 pm |
N/A 2032-01-03 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
61,800 | $0 | 80,178 (Direct) |
View |
2022-01-01 Tax Withholding |
2022-01-04 9:04 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,221 | $32.7 | 80,178 (Direct) |
View |
2021-06-30 Option Award |
2022-01-04 9:04 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
555 | $33.02 | 80,178 (Direct) |
View |
2021-12-31 Option Award |
2022-01-04 9:04 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1 | $27.8 | 80,178 (Direct) |
View |
2020-06-30 Option Award |
2021-01-06 08:53 am |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
641 | $31.31 | 71,543 (Direct) |
View |
2021-01-04 Option Award |
2021-01-06 08:53 am |
N/A 2031-01-04 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
64,100 | $0 | 71,543 (Direct) |
View |
2019-12-31 Option Award |
2021-01-06 08:53 am |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
302 | $34.82 | 71,543 (Direct) |
View |